ISOPP Biosimilar Education Need Assessment Survey

The International Society of Oncology Pharmacy Practitioners (ISOPP) is conducting this survey to understand the current educational needs of members around the use of biosimilars. The survey will inform the Biosimilars Task Force in the development of educational activities and resources to assist oncology pharmacy practitioners when implementing biosimilar medicines into their local practice. 

Your responses will be anonymous and will be collated and summarized into a report.  We would greatly appreciate you taking about 15 minutes to complete this very important survey before Monday, February 18, 2019.

https://www.surveymonkey.com/r/isoppbiosimilars-survey-for-non-member
 
ISOPP Biosimilars Task Force
[email protected]  

Emma Foreman
BOPA Executive Committee Member
 

Latest News

By BOPA on 16th April 2024

Abstract Submission for #BOPA2024 is NOW OPEN

Abstract Submission for the 27th Annual BOPA Conference in 2024 is now OPEN   Delegates are invited to present results of their clinical and technical work as a poster with…

Read article
By BOPA Research Subcommittee on 15th April 2024

Survey: Service Evaluation on Carboplatin Variation in UK

We invite members to complete this service evaluation to understand national variations in carboplatin dosing for adult patients receiving SACTs. We are looking at whether we can standardise carboplatin protocols…

Read article
By BOPA on 11th April 2024

My Research Webinar – April 2024

Thursday 25th April 2024 1-2pm BST   Register for the Session HERE: https://www.bopa.org.uk/webinarsignupform/   We would like to invite you to join our  ‘My Research’ sessions. These sessions are delivered…

Read article
By BOPA Committee on 10th April 2024

Independent UK Pharmacy Professional Leadership Advisory Board launched to strengthen collaboration

BOPA is proud to be part of the UK PPL Board and represent all Pharmacy Professionals and Cancer Pharmacy Professionals across the UK. For more information see the letter on…

Read article